N4 Pharma (GB:N4P) has released an update.
N4 Pharma PLC experienced a notable change in its shareholder structure when David Farrier’s voting rights crossed a certain threshold on June 13, 2024, resulting in a decrease from 7% to 4.8% of the total voting rights. This shift comes after the company increased its issued share capital earlier that month. The notification of this change was filed on June 18, 2024, detailing the updated distribution of voting rights among shareholders.
For further insights into GB:N4P stock, check out TipRanks’ Stock Analysis page.
